Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Current Leases (2019 - 2025)

AC Immune has reported Current Leases over the past 7 years, most recently at $1.1 million for Q4 2025.

  • Quarterly Current Leases fell 8.98% to $1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.1 million through Dec 2025, down 8.98% year-over-year, with the annual reading at $1.1 million for FY2025, 8.98% down from the prior year.
  • Current Leases was $1.1 million for Q4 2025 at AC Immune, down from $1.3 million in the prior quarter.
  • Over five years, Current Leases peaked at $757.6 million in Q4 2023 and troughed at $568836.0 in Q4 2022.
  • The 5-year median for Current Leases is $933508.2 (2024), against an average of $156.5 million.
  • Year-over-year, Current Leases skyrocketed 137655.92% in 2021 and then crashed 99.91% in 2022.
  • A 5-year view of Current Leases shows it stood at $618.2 million in 2021, then crashed by 99.91% to $568836.0 in 2022, then skyrocketed by 133081.13% to $757.6 million in 2023, then tumbled by 99.85% to $1.2 million in 2024, then dropped by 8.98% to $1.1 million in 2025.
  • Per Business Quant, the three most recent readings for ACIU's Current Leases are $1.1 million (Q4 2025), $1.3 million (Q3 2025), and $1.3 million (Q2 2025).